Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.

Saha M, Rizzo SA, Ramanathan M, Hightower RM, Santostefano KE, Terada N, Finkel RS, Berg JS, Chahin N, Pacak CA, Wagner RE, Alexander MS, Draper I, Kang PB

Open source

DOI
10.1093/hmg/ddz064
Published
2019 Jul 15
Container
Human molecular genetics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/hmg/ddz064,
  title = {Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.},
  author = {Saha M and Rizzo SA and Ramanathan M and Hightower RM and Santostefano KE and Terada N and Finkel RS and Berg JS and Chahin N and Pacak CA and Wagner RE and Alexander MS and Draper I and Kang PB},
  year = {2019},
  journal = {Human molecular genetics},
  doi = {10.1093/hmg/ddz064},
  url = {https://doi.org/10.1093/hmg/ddz064}
}

RIS

TY  - JOUR
TI  - Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.
AU  - Saha M
AU  - Rizzo SA
AU  - Ramanathan M
AU  - Hightower RM
AU  - Santostefano KE
AU  - Terada N
AU  - Finkel RS
AU  - Berg JS
AU  - Chahin N
AU  - Pacak CA
AU  - Wagner RE
AU  - Alexander MS
AU  - Draper I
AU  - Kang PB
PY  - 2019
JO  - Human molecular genetics
DO  - 10.1093/hmg/ddz064
UR  - https://doi.org/10.1093/hmg/ddz064
ER  - 

APA

M, S., SA, R., M, R., RM, H., KE, S., N, T., RS, F., JS, B., N, C., CA, P., RE, W., MS, A., I, D., & PB, K. (2019). Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.. Human molecular genetics. https://doi.org/10.1093/hmg/ddz064

Source records